iSpecimen (NASDAQ:ISPC) Posts Quarterly Earnings Results

Posted by Tammy Falkenburg on Nov 17th, 2025

iSpecimen (NASDAQ:ISPC – Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.48) earnings per share (EPS) for the quarter, Zacks reports. iSpecimen had a negative net margin of 172.48% and a negative return on equity of 395.15%.

iSpecimen Price Performance

Shares of NASDAQ ISPC traded down $0.05 during midday trading on Monday, reaching $0.58. 142,469 shares of the stock were exchanged, compared to its average volume of 2,303,719. iSpecimen has a 12 month low of $0.55 and a 12 month high of $4.90. The company has a market capitalization of $5.67 million, a price-to-earnings ratio of -0.06 and a beta of 1.76. The business has a 50-day simple moving average of $1.04 and a two-hundred day simple moving average of $1.07.

Hedge Funds Weigh In On iSpecimen

An institutional investor recently bought a new position in iSpecimen stock. Scientech Research LLC bought a new stake in iSpecimen Inc. (NASDAQ:ISPC – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 29,488 shares of the company’s stock, valued at approximately $38,000. Scientech Research LLC owned approximately 0.30% of iSpecimen at the end of the most recent quarter. Hedge funds and other institutional investors own 13.62% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on ISPC. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of iSpecimen in a research note on Wednesday, October 8th. Wall Street Zen raised shares of iSpecimen to a “sell” rating in a research note on Saturday, September 6th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

Check Out Our Latest Stock Report on ISPC

iSpecimen Company Profile

(Get Free Report)

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.